PROGRAMME 13 April
| Exhibition room | |
| 15:00 | Welcome Organizing committee, Carsten Niemann |
| 15:05 | The patients' perspective Olav Ljosne - the Norwegian blood cancer association |
| 15:10 | The genomic landscape of CLL Richard Rosenquist (Stockholm) |
| 15:22 | CLL treatment - getting personal Sigrid Skånland (Oslo) |
| 15:34 | Open discussion All panelists |
| Break | Exhibition room |
| 16:00 | Symposium – Industry sponsored session AbbVie CLL- therapy in frontline and beyond - novel options and sequential use. Role of anti-CD20 antibodies in CLL-treatment. Speaker: Dr. Othman Al-Sawaf |
| Break | Exhibition room |
| 16:47 | The microbiome of CLL Tereza Faitova (Copenhagen) |
| 16:59 | COVID-19 and CLL Rebecka Svanberg (Copenhagen) |
| 17:11 | How to treat the elderly Matthew Davids (Boston) |
| 17:23 | Open discussion All panelists |
| 17:43 | Symposium – Industry sponsored session Janssen The role of transplantation and post-transplant intervention in the era of novel agents Speaker: Carolina Moreno Atanasio (Barcelona) |
| 18:00 | Exhibition room |
ASTRAZENECA SYMPOSIUM 14 APRIL
| 15:00-15:15 | Welcome |
| 15:15-16:45 | Multidisciplinary team discussions on making therapeutic choices in management of treatment naïve and relapse/refractory CLL |
| 16:45-17:00 | Q&A and closing remarks |
Main sponsors:
2021 © NCLLSG
Website by Gyro Conference
Exhibitor:
